This article is for informational purposes only and does not constitute medical or health advice. Dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult a qualified healthcare provider before starting any new supplement.
By PerformixHouse.com Editorial Team
The berberine patch category has grown enough in 2026 that comparison research is now a legitimate consumer need. Three brands account for most of the search traffic and retail presence in the transdermal berberine space: Purisaki Berberine Patches, PatchMD's GLP-1 Support Patch, and Kind Patches Berberine. A fourth option — oral berberine capsules in their various formulations — remains the format with the strongest published evidence base and is the comparison standard every patch product implicitly invokes. This guide evaluates all four across the decision points that actually matter for a performance-oriented gym-goer who evaluates supplements the same way they evaluate training inputs: mechanism, dose, evidence, cost, and policy.
The Comparison Framework — Five Decision Points That Matter
Ingredient transparency: does the product disclose per-serving ingredient amounts? Without milligram disclosures, comparing any supplement to the published research standard is structurally impossible. This is decision point one because it determines whether every other comparison can even be made.
Evidence base: what format of delivery does the published research support, and does this product's format align with that evidence? For berberine, this means distinguishing between the extensive oral research base and the minimal transdermal human data.
Formulation breadth: how many active compounds does the product include, and are they selected for pharmacological rationale or marketing narrative? More ingredients is not inherently better — it complicates the evidence picture further.
Pricing and value per serving: what is the actual cost per patch per day at various volume levels, and what is the return policy if the product doesn't work for you?
Policy transparency: does the brand disclose return terms, ingredient sourcing, contact information, and company registration clearly? Transparency on policy is a proxy for transparency on everything else.
Purisaki Berberine Patches
Purisaki is operated by UAB BeWell EU, registered in Vilnius, Lithuania (company registration number 305788600), with a U.S. returns center in Wayne, NJ. The patch is worn for 8 hours daily applied to clean dry skin. The ingredient list per the brand's official website includes berberine extract, fucoxanthin extract, pomegranate oil (punicic acid extract), green tea extract, African mango extract, vitamins C, B1, and B3, plus nine additional unnamed natural ingredients. Per-patch milligram amounts are not publicly disclosed for any ingredient.
Pricing at time of publication: 1 pack $60.57; 2 packs $60.56 total ($30.28/pack); 3 packs $81.70 total ($27.23/pack); 4 packs $90.80 total ($22.70/pack). Shipping is $4.95. The return policy is 60 days from delivery — full refund within the first 14 days; after that, fees may apply. An RMA code from customer support is required before returning. Customer contact: US +1 (850) 389-0125, [email protected].
On ingredient transparency: no milligram amounts disclosed. On evidence: the oral berberine research base is real; whether the transdermal format delivers comparable doses has not been validated in published human studies. The 4.3-star / 8,658+ review count is notable social proof, though the Terms of Service (Section 11.2) disclose that testimonial names and images may be fictional. Strongest comparison point: the 60-day return window and verified company registration give it the clearest policy transparency of the three patch products. For a full detailed review, see Purisaki Berberine Patches Review 2026: Delivery Science Decoded.
PatchMD GLP-1 Support Patch
PatchMD is a U.S.-based company with a longer track record in the transdermal supplement category than either Purisaki or Kind Patches — the company has operated since 2010 with a catalog of over 50 formulations. Their GLP-1 Support Patch positions itself as a comprehensive metabolic support product, combining berberine with 12 additional targeted compounds including alpha-lipoic acid, CoQ10, bitter melon extract, gymnema sylvestre, chromium, and green tea extract, among others. The formulation is described as doctor-informed.
Pricing per publicly available information: approximately $22.95 per package, with a subscription option at approximately 40% off ($13.77). This positions PatchMD as significantly less expensive per 30-day supply than Purisaki at equivalent pack sizes. The company offers a satisfaction guarantee, though specific return terms should be confirmed on the PatchMD website before purchasing.
On ingredient transparency: PatchMD's ingredient list is more detailed than Purisaki's in terms of naming compounds, but per-patch milligram amounts for the berberine component are also not prominently disclosed in public materials. On evidence: the multi-ingredient approach adds compounds that have individual published research in metabolic contexts (gymnema and blood sugar, CoQ10 and mitochondrial function), but the same fundamental question applies — transdermal delivery of any of these compounds through a consumer adhesive patch lacks human pharmacokinetic validation. PatchMD's advantage is brand longevity and the credibility of a U.S.-registered company with a longer publishing and regulatory history in the supplement space.
Kind Patches Berberine Patches
Kind Patches is a newer entrant to the transdermal supplement market with distribution through Ulta Beauty and other retail channels. The formulation is the most transparent of the three patch brands in terms of publicly disclosed amounts: per the brand's product page and Ulta listing, each patch contains berberine extract 8.75 mg, pomegranate extract 1.75 mg, cinnamon extract 2.75 mg (in a 13.25 mg proprietary blend), vitamin B complex (B1, B2, B3, B6, B9, B12) 8.25 mg, L-glutamine 3.5 mg, and chromium 35 mcg.
This transparency is the clearest competitive differentiator for Kind Patches. It also reveals the dose math problem most directly: 8.75 mg of berberine per patch versus the 900 to 1,500 mg daily oral standard used in published clinical research is a gap of approximately 100-fold. Whether transdermal delivery at 8.75 mg produces systemic berberine concentrations comparable to oral doses is the unanswered question — and Kind Patches' label transparency at least makes the question visible in a way the other brands don't. Pricing is approximately $15 to $20 for a 30-patch supply, making it the most budget-friendly of the three patches reviewed.
On evidence: same fundamental limitation as all consumer berberine patches — no human pharmacokinetic validation for the transdermal format. The simpler formulation (6 disclosed ingredient categories vs. Purisaki's 8+ and PatchMD's 13) means fewer interaction variables, which could be viewed as a lower-risk formulation approach for consumers who are otherwise healthy adults.
Oral Berberine Capsules — The Evidence Standard
Oral berberine supplementation in capsule or tablet form represents the format with the strongest published evidence base for metabolic outcomes. The 900 to 1,500 mg daily dosing used in published clinical trials is accessible in standard oral formulations at costs typically ranging from $15 to $40 per month, depending on the brand and formulation type. Enhanced formulations — phytosome berberine (for improved GI absorption) and dihydroberberine (DHB, a reduced form with higher theoretical bioavailability per gram) — command higher price points but offer the advantage of matching the research format more closely.
The trade-off: oral berberine causes GI side effects in a meaningful minority of users (estimated 10–15%), including cramping, bloating, and diarrhea. These effects are dose-dependent and can often be managed by splitting doses and taking with food. For users who cannot tolerate oral berberine, the transdermal format's GI side-effect avoidance is a genuine functional advantage — even if the absorption question is unresolved. For users who tolerate oral supplements without difficulty, standard oral berberine at disclosed doses with published clinical validation is the evidence-aligned choice.
Which Format for Which Situation
You have tried oral berberine and cannot tolerate the GI side effects, and you want to experiment with a pill-free format: any of the three patches reviewed here provide that option. Kind Patches is the most budget-accessible starting point, and its published per-patch amounts make the gap between supplement dose and research standard transparent — which is information, not necessarily a dealbreaker. Purisaki offers the clearest return policy of the three for a risk-managed trial. PatchMD offers the most comprehensive multi-ingredient formulation with the longest company track record.
You want the supplement format most aligned with the published berberine research: oral berberine capsules at 900 to 1,500 mg daily with disclosed milligram amounts. The published research base was built on this format, at these doses. If you tolerate oral supplements, this is the evidence-congruent choice.
You are managing a health condition or taking prescription medications: consult a physician before any berberine product in any format. The interaction profile described in our Berberine Safety Guide 2026 applies regardless of whether the delivery is oral or transdermal, because if transdermal absorption is meaningful, so is interaction potential.
Frequently Asked Questions
Is Purisaki better than PatchMD?
These products target the same category with comparable delivery formats but differ in formulation breadth, pricing, and company history. Purisaki has a more prominent consumer review presence (8,658+ reviews) and a clearly documented 60-day return window with verifiable contact information. PatchMD has a longer company history in transdermal supplements since 2010 and a multi-ingredient formulation that targets more metabolic pathways simultaneously. PatchMD is substantially less expensive per 30-day supply. Neither has published pharmacokinetic validation for transdermal berberine absorption in humans. The comparison is not clearly resolved in favor of either.
Are berberine patches as effective as capsules?
The published research base for berberine is built on oral capsule supplementation at 900 to 1,500 mg daily — and that research shows real, consistent metabolic effects. Whether consumer berberine patches deliver comparable systemic berberine levels is an unanswered question as of May 2026. No peer-reviewed human pharmacokinetic study has validated transdermal berberine absorption for consumer adhesive patches. For users who tolerate oral supplementation, capsules represent the format with the clearest evidence alignment.
What is the cheapest berberine patch option?
Kind Patches at approximately $15 to $20 for a 30-day supply is the most accessible price point among the three patch brands reviewed here. Its per-patch ingredient disclosure (8.75 mg berberine per patch) is also the most transparent of the three brands reviewed, which gives consumers the most information to work with even if the dose math reveals a large gap from the oral research standard.
For a full breakdown of how berberine works at the mechanism level, see How Berberine Works: The 2026 AMPK Pathway and Metabolic Research Overview. For the research evidence on specific berberine ingredients, see Berberine Supplement Research 2026: What the Studies Actually Show. For safety and drug interaction information, see Berberine Safety Guide 2026: Interactions, Contraindications, and When to Ask Your Doctor. For our complete Purisaki review including verified pricing and return policy details, see Purisaki Berberine Patches Review 2026: Delivery Science Decoded.
These statements have not been evaluated by the Food and Drug Administration. This article is produced by the PerformixHouse.com editorial team for informational purposes only. UAB BeWell EU formulated Purisaki Berberine Patches; PerformixHouse.com wrote this comparison independently.